A Phase II, Multicenter, Randomized, Placebo -Controlled, Study To Evaluate The Efficacy and Safety Of Intramuscular Peramivir 600 mg In Subjects With Uncomplicated Acute Influenza.
Phase of Trial: Phase II
Latest Information Update: 19 Feb 2015
At a glance
- Drugs Peramivir (Primary)
- Indications Influenza virus infections
- Focus Therapeutic Use
- Sponsors BioCryst Pharmaceuticals
- 13 May 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 15 Nov 2008 Planned end date changed from 1 Oct 2008 to 1 Apr 2009.
- 15 Jul 2008 New trial record.